Shuttle Pharmaceuticals Holdings, Inc.

8-K Regulation FD disclosure; Other events Jul 1, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jun 11, 2026 8-K Shareholder vote results May 27, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws May 7, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 10, 2026 8-K Results of operations (earnings release) Feb 17, 2026 8-K Director or officer change Feb 2, 2026 8-K Director or officer change Jan 12, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 29, 2025 8-K Director or officer change Nov 28, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity Nov 26, 2025 8-K Entered a material agreement; Terminated a material agreement; Exit or disposal costs Nov 21, 2025 8-K Delisting notice or listing-rule failure Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Unregistered sale of equity Nov 7, 2025 8-K Entered a material agreement; Terminated a material agreement Oct 21, 2025 8-K Entered a material agreement Sep 22, 2025 8-K Director or officer change Sep 18, 2025 8-K Director or officer change Sep 17, 2025 8-K Director or officer change Sep 8, 2025 8-K Director or officer change Sep 5, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change Jul 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 25, 2025 8-K Director or officer change May 28, 2025 8-K Director or officer change; Shareholder vote results May 15, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Other events Apr 21, 2025 8-K Other events Apr 10, 2025 8-K Entered a material agreement Apr 4, 2025 8-K Entered a material agreement; Director or officer change Mar 31, 2025 8-K Entered a material agreement Mar 25, 2025 8-K Entered a material agreement; Delisting notice or listing-rule failure; Regulation FD disclosure Mar 13, 2025 8-K Director or officer change; Other events Mar 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Director or officer change Feb 28, 2025 8-K Entered a material agreement Feb 27, 2025 8-K Results of operations (earnings release) Feb 26, 2025